Hippocampal sclerosis: MR prediction of seizure intractability

Epilepsia

Volumn 48, Issue 2, 2007, Pages 315-323

  Briellmann, Regula S ^a,b   Mark Wellard, R ^a,b   Masterton, Richard A J ^a   Abbott, David F ^a,b   Berkovic, Samuel F ^a,b,c   Jackson, Graeme D ^a,b  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c AUSTIN HEALTH   (Australia)

Author keywords

Hippocampal sclerosis; MRI; MRS; Seizures; Severity

Indexed keywords

CHOLINE; CREATINE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; N ACETYLASPARTIC ACID;

ADULT; AMYGDALOID NUCLEUS; ARTICLE; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL LOBE; HIPPOCAMPAL SCLEROSIS; HUMAN; INTRACTABLE EPILEPSY; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; TEMPORAL LOBE; TEMPORAL LOBE EPILEPSY; THALAMUS; THREE DIMENSIONAL IMAGING; WHITE MATTER;

ADULT; ASPARTIC ACID; CHOLINE; CREATINE; EPILEPSY, TEMPORAL LOBE; FEMALE; FUNCTIONAL LATERALITY; GLUTAMIC ACID; GLUTAMINE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PROGNOSIS; SCLEROSIS; SEVERITY OF ILLNESS INDEX; TEMPORAL LOBE;

EID: 33846850241     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2006.00932.x     Document Type: Article

References (44)

1. Andrade-Valenca LP, Valenca MM, Ribeiro LT, Matos AL, Sales LV, Velasco TR, Santos AC, Leite JP. (2003) Clinical and neuroimaging features of good and poor seizure control patients with mesial temporal lobe epilepsy and hippocampal atrophy. Epilepsia 44:807-814.
2. Baslow MH, Suckow RF, Gaynor K, Bhakoo KK, Marks N, Saito M, Duff K, Matsuoka Y, Berg MJ. (2003) Brain damage results in down-regulation of N-acetylaspartate as a neuronal osmolyte. Neuromolecular Medicine 3:95-104.
3. Benedek K, Juhasz C, Muzik O, Chugani DC, Chugani HT. (2004) Metabolic changes of subcortical structures in intractable focal epilepsy. Epilepsia 45:1100-1105.
4. Berkovic SF, Andermann F, Olivier A, Ethier R, Melanson D, Robitaille Y, Kuzniecky R, Peters T, Feindel W. (1991) Hippocampal sclerosis in temporal lobe epilepsy demonstrated by magnetic resonance imaging. Annals of Neurology 29:175-182.
5. Bernasconi A, Bernasconi N, Caramanos Z, Reutens DC, Andermann F, Dubeau F, Tampieri D, Pike BG, Arnold DL. (2000) T2 relaxometry can lateralize mesial temporal lobe epilepsy in patients with normal MRI. Neuroimage 12:739-746.
6. Bernasconi N, Bernasconi A, Caramanos Z, Antel SB, Andermann F, Arnold DL. (2003) Mesial temporal damage in temporal lobe epilepsy: a volumetric MRI study of the hippocampus, amygdala and parahippocampal region. Brain 126:462-469.
7. Bernasconi N, Duchesne S, Janke A, Lerch J, Collins DL, Bernasconi A. (2004) Whole-brain voxel-based statistical analysis of gray matter and white matter in temporal lobe epilepsy. Neuroimage 23:717-723.
8. Briellmann RS, Berkovic SF, Jackson GD. (2000) Men may be more vulnerable to seizure associated brain damage. Neurology 55:1479-1485.
9. Briellmann RS, Jackson GD, Pell GS, Mitchell LA, Abbott DF. (2004a) Structural abnormalities remote from the seizure focus: a study using T2 relaxometry at 3 T. Neurology 63:2303-2308.
10. Briellmann RS, Jackson GD, Torn-Broers Y, Berkovic SF. (2001) Causes of epilepsies: insights from discordant monozygous twins. Annals of Neurology 49:45-52.
11. Briellmann RS, Pell GS, Wellard RM, Mitchell LA, Abbott DF, Jackson GD. (2003) MR imaging of epilepsy: state of the art at 1.5T and potential of 3T. Epilepsy Disorders 5:3-20.
12. Briellmann RS, Syngeniotis A, Fleming S, Kalnins RM, Abbott DF, Jackson GD. (2004b) Increased anterior temporal lobe T2 times in cases of hippocampal sclerosis: a multi-echo T2 relaxometry study at 3 T. American Journal of Neuroradiology 25:389-394.
13. Cendes F, Andermann F, Dubeau F, Matthews PM, Arnold DL. (1997) Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy: evidence from proton MR spectroscopic imaging. Neurology 49:1525-1533.
14. Connelly A, van Paesschen W, Proter DA, Johnson CL, Duncan JS, Gadian DG. (1998) Proton magnetic resonance spectroscopy in MRI-negative temporal lobe epilepsy. Neurology 51:61-66.
15. Cook MJ, Fish DR, Shorvon SD, Straughan K, Stevens JM. (1992) Hippocampal volumetric and morphometric studies in frontal and temporal lobe epilepsy. Brain 115:1001-1015.
16. Danielsen ER, Ross B. (1999) The clinical significance of metabolites. In Danielsen ER, Ross B (Eds). Magnetic resonance spectroscopy of neurological diseases. Marcel Dekker, New York, pp. 23-42.
17. Duc CO, Trabesinger AH, Weber O, Meier D, Walder M, Wieser HG, Boesinger P. (1998) Quantitative 1H MRS in the evaluation of mesial temporal lobe epilepsy in vivo. Magnetic Resonance Imaging 16:969-979.
18. Ferreira FT, Kobayashi E, Lopes-Cendes I, Cendes F. (2004) Structural abnormalities are similar in familial and nonfamilial mesial temporal lobe epilepsy. Canadian Journal of Neurological Science 31:368-372.
19. Jack CR. (1994) MRI-based hippocampal volume measurements in epilepsy. Epilepsia 35(suppl 6):S21-S29.
20. Jackson GD. (1995) The diagnosis of hippocampal sclerosis: other techniques. Magnetic Resonance Imaging 13:1081-1093.
21. Jackson GD, Berkovic SF, Duncan JS, Connelly A. (1993) Optimizing the diagnosis of hippocampal sclerosis using magnetic resonance imaging. American Journal of Neuroradiology 14:753-762.
22. Keller SS, Wilke M, Wieshmann UC, Sluming VA, Roberts N. (2004) Comparison of standard and optimized voxel-based morphometry for analysis of brain changes associated with temporal lobe epilepsy. Neuroimage 23:860-868.
23. Kim WJ, Park SC, Lee SJ, Lee JH, Kim JY, Lee BI, Kim DI. (1999) The prognosis for control of seizures with medications in patients with MRI evidence for mesial temporal sclerosis. Epilepsia 40:290-293.
24. Kobayashi E, D'Agostino MD, Lopes-Cendes I, Berkovic SF, Li ML, Andermann E, Andermann F, Cendes F. (2003) Hippocampal atrophy and T2-weighted signal changes in familial mesial temporal lobe epilepsy. Neurology 60:405-409.
25. Kobayashi E, Li LM, Lopes-Cendes I, Cendes F. (2002) Magnetic resonance imaging evidence of hippocampal sclerosis in asymptomatic, first-degree relatives of patients with familial mesial temporal lobe epilepsy. Archives of Neurology 59:1891-1894.
26. Kobayashi E, Lopes-Cendes I, Guerreiro CA, Sousa SC, Guerreiro MM, Cendes F. (2001) Seizure outcome and hippocampal atrophy in familial mesial temporal lobe epilepsy. Neurology 56:166-172.
27. Kuzniecky R, Palmer C, Hugg J, Martin R, Sawrie S, Morawetz R, Faught E, Knowlton R. (2001) Magnetic resonance spectroscopic imaging in temporal lobe epilepsy: neuronal dysfunction or cell loss? Archives of Neurology 58:2048-2053.
28. Marsh L, Morrell MJ, Shear PK, Sullican EV, Freeman H, Marie A, Lim KO, Pfefferbaum A. (1997) Cortical and hippocampal volume deficits in temporal lobe epilepsy. Epilepsia 38:576-587.
29. McMillan AB, Hermann BP, Johnson SC, Hansen RR, Seidenberg M, Meyerand ME. (2004) Voxel-based morphometry of unilateral temporal lobe epilepsy reveals abnormalities in cerebral white matter. Neuroimage 23:167-74.
30. Mitchell LA, Harvey AS, Coleman LT, Mandelstam S, Jackson GD. (2003) Anterior temporal changes in children with hippocampal sclerosis: an effect of seizures on the immature brain? American Journal of Neuroradiology 24:1670-1677.
31. Mitchell LA, Jackson GD, Kalnins RM, Saling MM, Fitt GJ, Ashpole RD, Berkovic SF. (1999) Anterior temporal abnormality in temporal lobe epilepsy: a quantitative MRI and histopathologic study. Neurology 52:327-336.
32. Mueller SG, Suhy J, Laxer KD, Flenniken DL, Axelrad J, Capizzano AA, Weiner MW. (2002) Reduced extrahippocampal NAA in mesial temporal lobe epilepsy. Epilepsia 43:1210-1216.
33. Ozkara C, Hanoglu L, Keskinkilic C, Yeni N, Aysal F, Uzan M, Ozyurt E, Karaagac N. (2004) Memory in patients with drug-responsive mesial temporal lobe epilepsy and hippocampal sclerosis. Epilepsia 45:1392-1396.
34. Pell GS, Briellmann RS, Waites AB, Abbott DF, Lewis DP, Jackson GD. (2006) Optimized clinical T2 relaxometry with a standard CPMG sequence. Journal of Magnetic Resonance Imaging 23:248-252.
35. Petroff OA, Errante LD, Kim JH, Spencer DD. (2003) N-acetyl-aspartate, total creatine, and myo-inositol in the epileptogenic human hippocampus. Neurology 60:1646-1651.
36. Petroff OA, Errante LD, Rothman DL. (2002) Glutamate-glutamine cycling in the epileptic human hippocampus. Epilepsia 43:703-710.
37. Pitkänen A, Laakso M, Kälviäinen R, Partanen K, Vainio P, Lehtovirta M, Riekkinen P, Soininen H. (1996) Severity of hippocampal atrophy correlates with the prolongation of MRI T2 relaxation time in temporal lobe epilepsy but not in Alzheimer's disease. Neurology 46:1724-1730.
38. Provencher SW. (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magnetic Resonance Medicine 30:672-679.
39. Scott RC, Cross JH, Gadian DG, Jackson GD, Neville BG, Connelly A. (2003) Abnormalities in hippocampi remote from the seizure focus: a T2 relaxometry study. Brain 126:1968-1974.
40. Solinas C, Briellmann RS, Harvey AS, Mitchell LA, Berkovic SF. (2003) Hypertensive encephalopathy: antecedent to hippocampal sclerosis and temporal lobe epilepsy? Neurology 60:1534-1536.
41. Townsend TN, Bernasconi N, Pike GB, Bernasconi A. (2004) Quantitative analysis of temporal lobe white matter T2 relaxation time in temporal lobe epilepsy. Neuroimage 23:318-324.
42. Urenjak J, Williams SR, Gadian DG, Noble M. (1992) Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. Journal of Neurochemistry 59:55-61.
43. Urenjak J, Williams SR, Gadian DG, Noble M. (1993) Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. Journal of Neuroscience 13:981-989.
44. Wellard RM, Briellmann RS, Prichard JW, Syngeniotis A, Jackson GD. (2003) Myoinositol abnormalities in temporal lobe epilepsy. Epilepsia 44:815-821.